|
1.
Share Success: Letters From Readers
Letter
I: From Karen P.
Received
at Customer Service Sunday, August 5, 2018 7:42 AM
(Unedited)
I have been taking EZorb for 3 months now and absolutely can not believe how it has totally eliminated my hip pain. I am supposed to have a hip replacement but now I keep pushing it off.
Letter II: From Rivka G.
Received
at Testimonial Submit Form Friday, May 25, 2018 8:55 AM
(Unedited)
Hi, my name is Rivka. I am almost 70 years old now. I started using Ezorb 12 years ago.
Four years ago after my bones were scanned and the result was not good you recommended to return to my startup dose (8 capsules a day).
A year after that the T-score did not improve and you recommended to stay on the startup dose and so I did.
Yesterday my bones were scanned after almost 3 years, and I am delighted to inform you that my hip T-score went up by an impressive 10.6%!!! and is now 2.6. (Instead of 3.1 previously).
My lumber spine T-score went up by 1 percent which is probably within the margin of error.
My wrist T-score did not change and is good. I am very happy with the results.
Many thanks!
Rivka
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Lupus Linked to Increased Cancer Risk
Findings from a meta-analysis indicate that systemic lupus erythematosus (SLE) is associated with an increased risk for 16 types of cancer.
"This evidence could be utilized to drive public policies and to help guide personalized medicine to better manage SLE and reduce associated cancer morbidity and mortality," say Yan Lu (The First Affiliated Hospital of Nanjing Medical University, China) and co-authors.
The team analyzed data from 24 studies, finding that patients with SLE had a significant 28% increased overall cancer risk compared with the general population, and the risk was significantly elevated in both men and women.
When the analysis was broken down by cancer type, SLE patients had a significantly elevated risk for 16 cancer types – including renal and bladder malignancy and various hematologic cancers, as well as lung, head and neck, and nonmelanoma skin cancer – relative to the general population.
On the other hand, SLE was associated with a reduced risk for prostate cancer and cutaneous melanoma, and there was no significant association between SLE and breast, ovarian, uterine, pancreatic, colorectal, or brain cancer.
Lu and colleagues conclude in Arthritis Research & Therapy that "future high-quality research is required to verify our findings and this should pay more attention to the underlying mechanisms" mediating the association between SLE and cancer risk.
Original article appeared in Original research was published in Arthritis Research & Therapy | 201820:270.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
